In this study, the authors created a model of colitis that did not respond to TNFα, thereby demonstrating that IL-1β expression was another major pathway in the progression of colitis, thus highlighting the importance of IL-1β in UC patients that do not respond to TNFα inhibition [60,61]. Here, IL1B is linked to colitis.